NCT07283705
- Conditions
- BMS-986504, MTAP-deleted Pancreatic Cancer, Phase 2 Study
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Phase 2 Study
Explore clinical trials studying Phase 2 Study. Study availability and eligibility vary by location and protocol.
3 public trials
2 recruiting studies
Phase 2 Study trial results
NCT07257055
- Conditions
- BTKi, Glofitamab, MCL, +2 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Not Yet Recruiting
Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell Acute Lymphoblastic Leukemia
NCT07192237
- Conditions
- Acute Lymphoblastic Leukemia, Blinatumomab, Hematologic Diseases, +11 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States